These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 23466486

  • 21. Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma.
    Clark CA, McEachern MD, Shah SH, Rong Y, Rong X, Smelley CL, Caldito GC, Abreo FW, Nathan CO.
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1586-95. PubMed ID: 20851953
    [Abstract] [Full Text] [Related]

  • 22. Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.
    Li W, Wang BE, Moran P, Lipari T, Ganesan R, Corpuz R, Ludlam MJ, Gogineni A, Koeppen H, Bunting S, Gao WQ, Kirchhofer D.
    Cancer Res; 2009 Nov 01; 69(21):8395-402. PubMed ID: 19843851
    [Abstract] [Full Text] [Related]

  • 23. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways.
    Liao S, Xia J, Chen Z, Zhang S, Ahmad A, Miele L, Sarkar FH, Wang Z.
    J Cell Biochem; 2011 Apr 01; 112(4):1055-65. PubMed ID: 21308734
    [Abstract] [Full Text] [Related]

  • 24. Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.
    Das K, Lorena PD, Ng LK, Lim D, Shen L, Siow WY, Teh M, Reichardt JK, Salto-Tellez M.
    Endocr Relat Cancer; 2010 Sep 01; 17(3):757-70. PubMed ID: 20519274
    [Abstract] [Full Text] [Related]

  • 25. Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor.
    Guo H, Xu YM, Ye ZQ, Yu JH, Hu XY.
    Pharmazie; 2013 Jun 01; 68(6):431-4. PubMed ID: 23875250
    [Abstract] [Full Text] [Related]

  • 26. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
    Kuo PT, Lin TP, Liu LC, Huang CH, Lin JK, Kao JY, Way TD.
    J Agric Food Chem; 2009 Apr 22; 57(8):3331-9. PubMed ID: 19320436
    [Abstract] [Full Text] [Related]

  • 27. Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.
    Goswami R, Mukherjee S, Ghadiyaram C, Wohlfahrt G, Sistla RK, Nagaraj J, Satyam LK, Subbarao K, Palakurthy RK, Gopinath S, Krishnamurthy NR, Ikonen T, Moilanen A, Subramanya HS, Kallio P, Ramachandra M.
    Bioorg Med Chem; 2014 Jun 15; 22(12):3187-203. PubMed ID: 24794746
    [Abstract] [Full Text] [Related]

  • 28. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
    Chen A, Xu J.
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar 15; 288(3):G447-56. PubMed ID: 15486348
    [Abstract] [Full Text] [Related]

  • 29. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo.
    Sanders AJ, Parr C, Davies G, Martin TA, Lane J, Mason MD, Jiang WG.
    J Exp Ther Oncol; 2006 Mar 15; 6(1):39-48. PubMed ID: 17228523
    [Abstract] [Full Text] [Related]

  • 30. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).
    Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC, Chung JG.
    Cancer Lett; 2009 Nov 28; 285(2):127-33. PubMed ID: 19477063
    [Abstract] [Full Text] [Related]

  • 31. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
    Zarif JC, Lamb LE, Schulz VV, Nollet EA, Miranti CK.
    Oncotarget; 2015 Mar 30; 6(9):6862-76. PubMed ID: 25730905
    [Abstract] [Full Text] [Related]

  • 32. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
    Deng G, Yu JH, Ye ZQ, Hu ZQ.
    Zhonghua Nan Ke Xue; 2008 Feb 30; 14(2):116-21. PubMed ID: 18390174
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
    Dorai T, Dutcher JP, Dempster DW, Wiernik PH.
    Prostate; 2004 Jun 15; 60(1):1-17. PubMed ID: 15129424
    [Abstract] [Full Text] [Related]

  • 34. Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.
    Killian PH, Kronski E, Michalik KM, Barbieri O, Astigiano S, Sommerhoff CP, Pfeffer U, Nerlich AG, Bachmeier BE.
    Carcinogenesis; 2012 Dec 15; 33(12):2507-19. PubMed ID: 23042094
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
    Huang M, Narita S, Tsuchiya N, Ma Z, Numakura K, Obara T, Tsuruta H, Saito M, Inoue T, Horikawa Y, Satoh S, Habuchi T.
    Carcinogenesis; 2011 Nov 15; 32(11):1589-96. PubMed ID: 21828059
    [Abstract] [Full Text] [Related]

  • 36. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
    Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB.
    Oncogene; 2001 Nov 15; 20(52):7597-609. PubMed ID: 11753638
    [Abstract] [Full Text] [Related]

  • 37. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
    Kochuparambil ST, Al-Husein B, Goc A, Soliman S, Somanath PR.
    J Pharmacol Exp Ther; 2011 Feb 15; 336(2):496-505. PubMed ID: 21059805
    [Abstract] [Full Text] [Related]

  • 38. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
    Tsui KH, Feng TH, Lin CM, Chang PL, Juang HH.
    J Androl; 2008 Feb 15; 29(6):661-8. PubMed ID: 18676361
    [Abstract] [Full Text] [Related]

  • 39. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 15; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 40. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR.
    J Bone Miner Res; 2005 Dec 15; 20(12):2189-99. PubMed ID: 16294272
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.